THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE. IT DOES NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE.

+ −

Made by Allergan Aesthetics, world leader in medical aesthetics

A HEALTHY DIET AND EXERCISE ARE IMPORTANT.
This Medical Device must be applied by a healthcare professional. Always read and follow the instructions. Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinaemia, cold agglutinin disease or paroxysmal cold haemoglobinuria. Be careful using CoolSculpting® in pregnant or breastfeeding women, in patients who are sensitive to cold or to fructose, glycerin, isopropyl alcohol or propylene glycol; in patients with poor circulation, recent surgery, scar tissue, skin conditions such as eczema, dermatitis, or rashes in the area to be treated, nerve pain following shingles, nerve damage due to diabetes, poor skin sensation, open or infected wounds, bleeding disorders or use of blood thinners, hernia in or near the area to be treated; and in patients with implanted pacemakers and defibrillators.

During the procedure patients may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations subside as the area becomes numb. Following the procedure, side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. The following rare and very rare side effects have the following reported rates (approximate occurrences per number of treatments): paradoxical hyperplasia (1/3000 [0.033%]); late-onset pain (1/6000 [0.017%]); severe pain (1/6000 [0.017 %]); hyperpigmentation (1/11000 [0.009%]); freeze burn (1/15000 [0.007%]); treatment area demarcation (1/20000 [0.005%]); vasovagal symptoms (1/30000 [0.003%]); subcutaneous induration (1/30000 [0.003%]); cold panniculitis (1/60000 [0.002%]) and hernia (1/185000 [0.001%]). 

Individual patient results may vary. Images for illustrative purposes only.
*Data obtained from cryolipolysis investigations using a porcine model.
†As of May 2021.
‡As of November 2021.
◊As of December 2016.